164 related articles for article (PubMed ID: 12798954)
1. Multiple cellular electrophysiological effects of azimilide in canine cardiac preparations.
Takács J; Iost N; Lengyel C; Virág L; Nesic M; Varró A; Papp JG
Eur J Pharmacol; 2003 Jun; 470(3):163-70. PubMed ID: 12798954
[TBL] [Abstract][Full Text] [Related]
2. Azimilide (NE-10064) can prolong or shorten the action potential duration in canine ventricular myocytes: dependence on blockade of K, Ca, and Na channels.
Yao JA; Tseng GN
J Cardiovasc Electrophysiol; 1997 Feb; 8(2):184-98. PubMed ID: 9048249
[TBL] [Abstract][Full Text] [Related]
3. Azimilide causes reverse rate-dependent block while reducing both components of delayed-rectifier current in canine ventricular myocytes.
Gintant GA
J Cardiovasc Pharmacol; 1998 Jun; 31(6):945-53. PubMed ID: 9641481
[TBL] [Abstract][Full Text] [Related]
4. Combined potassium and calcium channel antagonistic activities as a basis for neutral frequency dependent increase in action potential duration: comparison between BRL-32872 and azimilide.
Bril A; Forest MC; Cheval B; Faivre JF
Cardiovasc Res; 1998 Jan; 37(1):130-40. PubMed ID: 9539867
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the rate-dependent properties of the class III antiarrhythmic agents azimilide (NE-10064) and E-4031: considerations on the mechanism of reverse rate-dependent action potential prolongation.
Groh WJ; Gibson KJ; Maylie JG
J Cardiovasc Electrophysiol; 1997 May; 8(5):529-36. PubMed ID: 9160229
[TBL] [Abstract][Full Text] [Related]
6. Use-dependent effects of the class III antiarrhythmic agent NE-10064 (azimilide) on cardiac repolarization: block of delayed rectifier potassium and L-type calcium currents.
Fermini B; Jurkiewicz NK; Jow B; Guinosso PJ; Baskin EP; Lynch JJ; Salata JJ
J Cardiovasc Pharmacol; 1995 Aug; 26(2):259-71. PubMed ID: 7475051
[TBL] [Abstract][Full Text] [Related]
7. Azimilide inhibits multiple cardiac potassium currents in human atrial myocytes.
Chen F; Esmailian F; Sun W; Wetzel GT; Sarma JS; Singh BN; Klitzner TS
J Cardiovasc Pharmacol Ther; 2002 Oct; 7(4):255-64. PubMed ID: 12490972
[TBL] [Abstract][Full Text] [Related]
8. Analysis of the electrophysiological effects of ambasilide, a new antiarrhythmic agent, in canine isolated ventricular muscle and purkinje fibers.
Baláti B; Iost N; Simon J; Varró A; Papp JG
Gen Pharmacol; 2000 Feb; 34(2):85-93. PubMed ID: 10974415
[TBL] [Abstract][Full Text] [Related]
9. Electrophysiological effects of EGIS-7229, a new antiarrhythmic agent, in isolated mammalian and human cardiac tissues.
Pankucsi C; Bányász T; Magyar J; Gyönös I; Kovács A; Varró A; Szénási G; Nánási PP
Naunyn Schmiedebergs Arch Pharmacol; 1997 Mar; 355(3):398-405. PubMed ID: 9089672
[TBL] [Abstract][Full Text] [Related]
10. I(Kr) vs. I(Ks) blockade and arrhythmogenicity in normoxic rabbit Purkinje fibers: does it really make a difference?
Puddu PE; Legrand JC; Sallé L; Rouet R; Ducroq J
Fundam Clin Pharmacol; 2011 Jun; 25(3):304-12. PubMed ID: 21241363
[TBL] [Abstract][Full Text] [Related]
11. Electrophysiological effects of bimoclomol in canine ventricular myocytes.
Magyar J; Bányász T; Szigligeti P; Körtvély A; Jednákovits A; Nánási PP
Naunyn Schmiedebergs Arch Pharmacol; 2000 Mar; 361(3):303-10. PubMed ID: 10731044
[TBL] [Abstract][Full Text] [Related]
12. Effects of azimilide on the muscarinic acetylcholine receptor-operated K+ current and experimental atrial fibrillation in guinea-pig hearts.
Nishida A; Reien Y; Ogura T; Uemura H; Tamagawa M; Yabana H; Nakaya H
J Pharmacol Sci; 2007 Nov; 105(3):229-39. PubMed ID: 17965539
[TBL] [Abstract][Full Text] [Related]
13. Cellular electrophysiological effect of terikalant in the dog heart.
Biliczki P; Acsai K; Virág L; Tálosi L; Jost N; Biliczki A; Papp JG; Varró A
Eur J Pharmacol; 2005 Mar; 510(3):161-6. PubMed ID: 15763239
[TBL] [Abstract][Full Text] [Related]
14. Electrophysiologic characterization of dronedarone in guinea pig ventricular cells.
Gautier P; Guillemare E; Marion A; Bertrand JP; Tourneur Y; Nisato D
J Cardiovasc Pharmacol; 2003 Feb; 41(2):191-202. PubMed ID: 12548079
[TBL] [Abstract][Full Text] [Related]
15. Effect of a neuroprotective drug, eliprodil on cardiac repolarisation: importance of the decreased repolarisation reserve in the development of proarrhythmic risk.
Lengyel C; Dézsi L; Biliczki P; Horváth C; Virág L; Iost N; Németh M; Tálosi L; Papp JG; Varró A
Br J Pharmacol; 2004 Sep; 143(1):152-8. PubMed ID: 15302678
[TBL] [Abstract][Full Text] [Related]
16. Effects of sildenafil on cardiac repolarization.
Chiang CE; Luk HN; Wang TM; Ding PY
Cardiovasc Res; 2002 Aug; 55(2):290-9. PubMed ID: 12123768
[TBL] [Abstract][Full Text] [Related]
17. Electrophysiological effects of azimilide in an in vitro model of simulated-ischemia and reperfusion in guinea-pig ventricular myocardium.
Ducroq J; Rouet R; Puddu PE; Sallé L; Tabourel C; Ducouret P; Gérard JL
Eur J Pharmacol; 2005 Aug; 518(2-3):165-74. PubMed ID: 16083874
[TBL] [Abstract][Full Text] [Related]
18. The role of the delayed rectifier component IKs in dog ventricular muscle and Purkinje fibre repolarization.
Varro A; Baláti B; Iost N; Takács J; Virág L; Lathrop DA; Csaba L; Tálosi L; Papp JG
J Physiol; 2000 Feb; 523 Pt 1(Pt 1):67-81. PubMed ID: 10675203
[TBL] [Abstract][Full Text] [Related]
19. Multiple cellular electrophysiological effects of a novel antiarrhythmic furoquinoline derivative HA-7 [N-benzyl-7-methoxy-2,3,4,9-tetrahydrofuro[2,3-b]quinoline-3,4-dione] in guinea pig cardiac preparations.
Chang GJ; Su MJ; Kuo SC; Lin TP; Lee YS
J Pharmacol Exp Ther; 2006 Jan; 316(1):380-91. PubMed ID: 16174797
[TBL] [Abstract][Full Text] [Related]
20. The effect of isoproterenol on the class III effect of azimilide in humans.
Dorian P; Dunnmon P; Elstun L; Newman D
J Cardiovasc Pharmacol Ther; 2002 Oct; 7(4):211-7. PubMed ID: 12490966
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
